Creative Medical Technology Holdings, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Creative Medical Technology Holdings, Inc. (CELZ) had Deferred Tax Assets, Operating Loss Carryforwards of $9.24 million as of 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-20
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.24M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $7.66M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.27M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.84M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $9.24M 10-K · filed 2026-03-20 |
| 2024-12-31 | $7.66M 10-K · filed 2026-03-20 |
| 2023-12-31 | $6.27M 10-K · filed 2025-03-14 |
| 2022-12-31 | $4.84M 10-K · filed 2024-03-22 |
| 2021-12-31 | $2.10M 10-K · filed 2023-03-31 |
| 2020-12-31 | $1.59M 10-K · filed 2022-03-30 |
| 2019-12-31 | $1.35M 10-K · filed 2021-03-17 |
| 2018-12-31 | $1.05M 10-K · filed 2020-04-06 |
| 2017-12-31 | $950.36K 10-K · filed 2019-04-01 |
| 2016-12-31 | $189.06K 10-K · filed 2018-03-29 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |